LEHI,
Utah, May 7, 2024 /PRNewswire/ -- Purple
Innovation, Inc. (NASDAQ: PRPL), a comfort innovation company known
for creating the "World's First No Pressure ™ Mattress," today
announced results for the first quarter ended March 31, 2024, which were in line with
guidance.
First Quarter Financial Summary (Comparisons versus First
Quarter 2023)1
- Net revenue increased 12.5% to $120.0
million compared to $106.7
million.
- Wholesale revenue increased 33.1% and Direct-to-Consumer (DTC)
revenue was consistent with the year ago period.
- Gross margin was 34.8% compared to 38.0%.
- Operating expenses were $64.9
million, or 54.0% of net revenue compared to $65.2 million, or 61.1% of net revenue.
- Operating loss was $(23.1)
million compared to an operating loss of $(24.6) million.
- In connection with refinancing our credit agreement in January,
we recognized a loss of $23.6 million
related to the change in fair value of our newly issued warrants, a
$3.4 million loss on debt
extinguishment and $4.5 million of
interest expense.
- Net loss was $(50.2) million as
compared to $(25.9) million.
- Adjusted net loss was $(20.4)
million, or $(0.19) per
diluted share as compared to $(14.0)
million, or $(0.14) per
diluted share.
- EBITDA was $(43.7) million
compared to $(19.0) million.
- Adjusted EBITDA was $(13.2)
million compared to $(7.1)
million.
- Cash and cash equivalents were $34.5
million at March 31,
2024.
Chief Executive Officer, Rob
DeMartini, said "We are encouraged by our start to the year
as our first quarter performance was in-line with our guidance
despite continued industry softness. Momentum in our business has
been accelerating since the mid-2023 launch of our new product
portfolio and brand repositioning, leading to market share gains
and a return to growth. We are making important progress executing
the key initiatives that we believe will deliver sequential
top-line improvement as 2024 unfolds and allow us to generate
positive adjusted EBITDA in the second half of the year.
Longer-term, we are confident that Purple's innovative and
differentiated sleep technology combined with the team and
strategies that we have in place will fuel profitable growth and
increased shareholder value."
____________________________
|
1 Reconciliations for non-GAAP
financial measures to the most directly comparable GAAP financial
measures are included in the "RECONCILIATION OF GAAP TO NON-GAAP
MEASURES" tables at the end of this press release.
|
First Quarter 2024 Review
First quarter 2024 net revenue increased 12.5% to $120.0 million, compared to $106.7 million in the first quarter of 2023. This
increase was driven by the positive response to the Company's new
product lineup and an increase in wholesale floor slots, partially
offset by soft industry-wide demand for home-related products in
the current operating environment. By channel, wholesale revenue
increased 33.1% and DTC revenue was consistent with the year ago
period. Within DTC, lower e-commerce revenue was offset by growth
in Purple retail showroom revenue driven by a shift in sales
towards higher ticket mattresses and the net addition of five
showrooms over the previous 12 months.
Gross margin for the first quarter 2024 decreased to 34.8%
compared to 38.0% in the year ago period. The decrease was
primarily attributable to a shift in revenue to the Company's
wholesale channel, which carries a lower margin profile than its
DTC channel, the use of airfreight in the first part of the
quarter, the liquidation of discontinued products, and costs
associated with product shipped early in the second quarter.
Operating expenses were $64.9
million, or 54.0% of net revenue for the first quarter of
2024 compared to $65.2 million, or
61.1% of net revenue in the year ago period. The reduction in
operating expenses was largely driven by a $3.9 million decrease in general and
administrative costs reflecting the non-recurrence of $5.9 million in legal and professional fees
incurred by the Board's Special Committee in the first quarter of
2023, partially offset by a $3.3
million increase in marketing and sales expense. Advertising
spend as a percentage of net revenues was 10.8% in the first
quarter of 2024 compared to 11.0% in the first quarter of 2023.
Operating loss was $(23.1) million
for the first quarter 2024 compared to $(24.6) million in the prior year period.
Net loss was $(50.2) million for
the first quarter 2024 compared to $(25.9)
million in the year ago period. Adjusted net loss, which
excludes adjustments for certain non-cash items and other items the
Company does not consider in the evaluation of ongoing operational
performance, including a $23.6
million loss on the change in fair value of the warrant
liability, $3.4 million of losses
associated with the extinguishment of debt and a $4.3 million gain from an insurance settlement,
was $(20.4) million, or $(0.19) per diluted share, compared to
$(14.0) million, or $(0.14) per diluted share in the prior year
period. Adjusted net income has also been adjusted to reflect an
estimated effective income tax rate of 25.9% for the current and
comparable prior year period.
EBITDA for the first quarter 2024 was $(43.7) million compared to $(19.0) million in the first quarter 2023.
Adjusted EBITDA was $(13.2) million
compared to Adjusted EBITDA of $(7.1)
million in the prior year period.
Balance Sheet
As of March 31, 2024, the Company
had cash and cash equivalents, of $34.5
million compared to $26.9
million as of December 31,
2023. In January 2024, Purple
amended and restated its two primary debt facilities into a new
$61 million term loan, thereby adding
an additional $22 million of
liquidity.
Inventories as of March 31, 2024
totaled $72.0 million, representing a
decrease of 17.9% compared with March 31,
2023, and an increase of 7.7% compared with December 31, 2023.
2024 Outlook
The Company is reiterating its 2024 outlook for full year net
revenue to be in the range of $540 to
$560 million and Adjusted EBITDA between $(20) million and $(10)
million. The Company still expects its quarterly revenue and
adjusted EBITDA performance to improve sequentially as it
progresses through the year with adjusted EBITDA projected to be
positive for the second half of 2024.
Conference Call and Webcast Information
Purple Innovation, Inc. will host a live conference call to
discuss financial results on May 7,
2024 at 4:30 p.m. Eastern
Time. To access the call dial (8880 396-8049 (domestic) or
(416) 764-8646 (international). The call is also being
webcast and can be accessed on the investor relations section of
the Company's website, investors.purple.com. After the conference
call, a webcast replay will remain available on the investor
relations section of the Company's website for 30 days.
About Purple
Purple, the leading premium mattress company with the #1 Gel
Grid technology in the world, the GelFlex® Grid,
thoughtfully engineers products that make restorative sleep
effortless for every kind of sleeper. The result of over 30 years
of innovation and in comfort technologies, Purple's GelFlex Grid is
the most significant advancement in mattresses in decades and is
proven to reduce aches and pains. It instantly adapts as you move,
balances temperature, relieves pressure and offers support in all
the right places. Purple products, including mattresses, pillows,
cushions, frames, sheets, and more, can be found online
at Purple.com, in 60 Purple stores and over 3,000 retailers
nationwide. Sleep Better. Live Purple.
Forward Looking Statements
Certain statements made in this release that are not historical
facts are "forward looking statements" within the meaning of the
"safe harbor" provisions of the United States Private Securities
Litigation Reform Act of 1995. Statements based on historical data
are not intended and should not be understood to indicate the
Company's expectations regarding future events. Forward-looking
statements provide current expectations or forecasts of future
events or determinations. These forward-looking statements are not
guarantees of future performance, conditions or results, and
involve a number of known and unknown risks, uncertainties,
assumptions and other important factors, many of which are outside
the Company's control, that could cause actual results or outcomes
to differ materially from those discussed in the forward-looking
statements. Factors that could influence the realization of
forward-looking statements include, among others: changes in
economic, financial and end-market conditions in the markets in
which we operate; fluctuations in raw material prices and cost of
labor; the financial condition of our customers and suppliers;
competitive pressures, including the need for technology
improvement, successful new product development and introduction;
changes in consumer demand, including pullbacks in consumer
spending; disruptions to our manufacturing processes; and the risk
factors outlined in the "Risk Factors" section of our Annual Report
on Form 10-K filed with the Securities and Exchange Commission on
March 12, 2024, and in our other
filings made with the SEC. The Company does not undertake any
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise,
except as required by law.
Non-GAAP Financial Measures
EBITDA, adjusted EBITDA, adjusted net income, and adjusted net
income per diluted share are non-GAAP financial measures that
remove the impact of certain non-cash and non-recurring costs.
Management believes that the use of such non-GAAP financial
measures provides investors with additional useful information with
respect to the impact of various adjustments, which we view as a
better measure of our operating performance. Refer to the attached
table for the reconciliation of such non-GAAP financial measures to
the most comparable GAAP financial measure.
With respect to the Company's Adjusted EBITDA outlook for the
second quarter and full year 2024, a quantitative reconciliation to
the corresponding GAAP information cannot be provided without
unreasonable effort because of the inherent difficulty of
accurately forecasting the occurrence and financial impact of the
various adjusting items necessary for such reconciliation that have
not yet occurred, are out of our control, or cannot be reasonably
predicted, including but not limited to warrant liabilities and
stock based compensation. For the same reasons, the Company is
unable to assess the probable significance of the unavailable
information, which could have a material impact on its future GAAP
financial results.
Investor Contact:
Brendon
Frey, ICR
brendon.frey@icrinc.com
203-682-8200
PURPLE INNOVATION,
INC. Condensed Consolidated Balance Sheets (in
thousands, except par value) (unaudited)
|
|
|
|
March 31,
2024
|
|
|
December 31,
2023
|
|
Assets
|
|
|
|
|
|
|
Current
assets:
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$
|
34,477
|
|
|
$
|
26,857
|
|
Accounts receivable, net
|
|
|
27,742
|
|
|
|
37,802
|
|
Inventories
|
|
|
72,028
|
|
|
|
66,878
|
|
Prepaid expenses
|
|
|
8,480
|
|
|
|
8,536
|
|
Other current assets
|
|
|
1,069
|
|
|
|
1,737
|
|
Total current
assets
|
|
|
143,796
|
|
|
|
141,810
|
|
Property and equipment,
net
|
|
|
122,468
|
|
|
|
128,661
|
|
Operating lease
right-of-use assets
|
|
|
92,643
|
|
|
|
95,767
|
|
Intangible assets,
net
|
|
|
21,206
|
|
|
|
22,196
|
|
Other long-term
assets
|
|
|
2,015
|
|
|
|
2,191
|
|
Total assets
|
|
$
|
382,128
|
|
|
$
|
390,625
|
|
|
|
|
|
|
|
|
|
|
Liabilities and
Stockholders' Equity
|
|
|
|
|
|
|
|
|
Current
liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$
|
39,948
|
|
|
$
|
49,831
|
|
Accrued compensation
|
|
|
9,788
|
|
|
|
5,064
|
|
Customer prepayments
|
|
|
3,994
|
|
|
|
5,718
|
|
Accrued rebates and allowances
|
|
|
8,526
|
|
|
|
13,243
|
|
Accrued warranty liabilities – current portion
|
|
|
8,644
|
|
|
|
9,793
|
|
Operating lease obligations – current portion
|
|
|
14,986
|
|
|
|
14,843
|
|
Other current liabilities
|
|
|
10,020
|
|
|
|
12,490
|
|
Total current
liabilities
|
|
|
95,906
|
|
|
|
110,982
|
|
Debt, net of current
portion
|
|
|
41,941
|
|
|
|
26,909
|
|
Accrued warranty
liabilities, net of current portion
|
|
|
27,315
|
|
|
|
25,798
|
|
Operating lease
obligations, net of current portion
|
|
|
105,618
|
|
|
|
109,094
|
|
Warrant
liabilities
|
|
|
43,170
|
|
|
|
—
|
|
Other long-term
liabilities
|
|
|
2,462
|
|
|
|
2,235
|
|
Total
liabilities
|
|
|
316,412
|
|
|
|
275,018
|
|
Commitments and
contingencies (Note 13)
|
|
|
|
|
|
|
|
|
Stockholders'
equity:
|
|
|
|
|
|
|
|
|
Class A common stock; $0.0001 par value, 210,000 shares authorized;
107,480
issued and outstanding at March 31,
2024 and 105,507 issued and outstanding at
December 31, 2023
|
|
|
11
|
|
|
|
11
|
|
Class B common stock; $0.0001 par value, 90,000 shares authorized;
205 issued and
outstanding at March 31, 2024 and at
December 31, 2023
|
|
|
—
|
|
|
|
—
|
|
Additional paid-in capital
|
|
|
591,724
|
|
|
|
591,380
|
|
Accumulated deficit
|
|
|
(526,186)
|
|
|
|
(475,969)
|
|
Total stockholders'
equity attributable to Purple Innovation, Inc.
|
|
|
65,549
|
|
|
|
115,422
|
|
Noncontrolling interest
|
|
|
167
|
|
|
|
185
|
|
Total stockholders'
equity
|
|
|
65,716
|
|
|
|
115,607
|
|
Total liabilities and
stockholders' equity
|
|
$
|
382,128
|
|
|
$
|
390,625
|
|
PURPLE INNOVATION,
INC. Condensed Consolidated Statements of
Income (in thousands, except per share
amounts) (unaudited)
|
|
|
|
Three Months
Ended
March 31,
|
|
|
|
2024
|
|
|
2023
|
|
|
|
|
|
|
|
|
Revenues,
net
|
|
$
|
120,033
|
|
|
$
|
106,727
|
|
Cost of
revenues
|
|
|
78,313
|
|
|
|
66,149
|
|
Gross profit
|
|
|
41,720
|
|
|
|
40,578
|
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
Marketing and
sales
|
|
|
41,462
|
|
|
|
38,173
|
|
General and
administrative
|
|
|
19,728
|
|
|
|
23,667
|
|
Research and
development
|
|
|
3,666
|
|
|
|
3,372
|
|
Total operating
expenses
|
|
|
64,856
|
|
|
|
65,212
|
|
Operating
loss
|
|
|
(23,136)
|
|
|
|
(24,634)
|
|
Other income
(expense):
|
|
|
|
|
|
|
|
|
Interest
expense
|
|
|
(4,474)
|
|
|
|
(202)
|
|
Other income,
net
|
|
|
4,394
|
|
|
|
73
|
|
Loss on extinguishment
of debt
|
|
|
(3,394)
|
|
|
|
(1,217)
|
|
Change in fair value –
warrant liabilities
|
|
|
(23,599)
|
|
|
|
—
|
|
Total other expense,
net
|
|
|
(27,073)
|
|
|
|
(1,346)
|
|
Net loss before income
taxes
|
|
|
(50,209)
|
|
|
|
(25,980)
|
|
Income tax benefit
(expense)
|
|
|
(59)
|
|
|
|
(72)
|
|
Net loss
|
|
|
(50,268)
|
|
|
|
(26,052)
|
|
Net loss attributable
to noncontrolling interest
|
|
|
(51)
|
|
|
|
(119)
|
|
Net loss attributable
to Purple Innovation, Inc.
|
|
$
|
(50,217)
|
|
|
$
|
(25,933)
|
|
|
|
|
|
|
|
|
|
|
Net loss per
share:
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
(0.47)
|
|
|
$
|
(0.26)
|
|
Diluted
|
|
$
|
(0.47)
|
|
|
$
|
(0.26)
|
|
Weighted average common
shares outstanding:
|
|
|
|
|
|
|
|
|
Basic
|
|
|
106,022
|
|
|
|
98,404
|
|
Diluted
|
|
|
106,022
|
|
|
|
98,852
|
|
PURPLE INNOVATION,
INC. Condensed Consolidated Statements of Cash
Flows (in thousands) (unaudited)
|
|
|
|
Three Months
Ended
March 31,
|
|
|
|
2024
|
|
|
2023
|
|
Cash flows from
operating activities:
|
|
|
|
|
|
|
Net loss
|
|
$
|
(50,268)
|
|
|
$
|
(26,052)
|
|
Adjustments to
reconcile net loss to net cash used in operating
activities:
|
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
|
|
6,382
|
|
|
|
6,883
|
|
Non-cash
interest
|
|
|
1,563
|
|
|
|
270
|
|
Paid-in-kind
interest
|
|
|
1,850
|
|
|
|
—
|
|
Change in fair value –
warrant liabilities
|
|
|
23,599
|
|
|
|
—
|
|
Loss on extinguishment
of debt
|
|
|
3,394
|
|
|
|
1,217
|
|
Stock-based
compensation
|
|
|
492
|
|
|
|
1,192
|
|
Loss on disposal of
property and equipment
|
|
|
112
|
|
|
|
—
|
|
Changes in operating
assets and liabilities:
|
|
|
|
|
|
|
|
|
Accounts
receivable
|
|
|
10,060
|
|
|
|
20,124
|
|
Inventories
|
|
|
(5,150)
|
|
|
|
(14,484)
|
|
Prepaid expenses and
other assets
|
|
|
66
|
|
|
|
903
|
|
Operating leases,
net
|
|
|
(209)
|
|
|
|
1,076
|
|
Accounts
payable
|
|
|
(7,043)
|
|
|
|
1,223
|
|
Accrued
compensation
|
|
|
4,724
|
|
|
|
2,889
|
|
Customer
prepayments
|
|
|
(1,724)
|
|
|
|
(1,599)
|
|
Accrued rebates and
allowances
|
|
|
(4,717)
|
|
|
|
(6,822)
|
|
Accrued warranty
liabilities
|
|
|
368
|
|
|
|
1,898
|
|
Other accrued
liabilities
|
|
|
(313)
|
|
|
|
(2,221)
|
|
Net cash used in
operating activities
|
|
|
(16,814)
|
|
|
|
(13,503)
|
|
|
|
|
|
|
|
|
|
|
Cash flows from
investing activities:
|
|
|
|
|
|
|
|
|
Purchase of property and equipment
|
|
|
(3,038)
|
|
|
|
(2,943)
|
|
Investment in intangible assets
|
|
|
(62)
|
|
|
|
(155)
|
|
Net cash used in
investing activities
|
|
|
(3,100)
|
|
|
|
(3,098)
|
|
|
|
|
|
|
|
|
|
|
Cash flows from
financing activities:
|
|
|
|
|
|
|
|
|
Payments on term loan
|
|
|
(25,000)
|
|
|
|
(24,656)
|
|
Payments on revolving line of credit
|
|
|
(5,000)
|
|
|
|
—
|
|
Proceeds from related party loan
|
|
|
61,000
|
|
|
|
—
|
|
Payments for debt issuance costs
|
|
|
(3,466)
|
|
|
|
(2,898)
|
|
Proceeds from stock offering
|
|
|
—
|
|
|
|
60,300
|
|
Payments for public offering costs
|
|
|
—
|
|
|
|
(3,100)
|
|
Tax receivable agreement payments
|
|
|
—
|
|
|
|
(269)
|
|
Net cash provided by
financing activities
|
|
|
27,534
|
|
|
|
29,377
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease)
in cash
|
|
|
7,620
|
|
|
|
12,776
|
|
Cash, cash equivalents and restricted cash, beginning of the
year
|
|
|
26,857
|
|
|
|
41,754
|
|
Cash, cash equivalents and restricted cash, end of the
period
|
|
$
|
34,477
|
|
|
$
|
54,530
|
|
PURPLE INNOVATION,
INC.
RECONCILIATION OF GAAP TO NON-GAAP
MEASURES
(in thousands, except per share
amounts)(unaudited)
Management believes that the use of the following non-GAAP
financial measures provides investors with additional useful
information with respect to the impact of various adjustments,
which we view as a better measure of our operating performance.
These non-GAAP financial measures are EBITDA and adjusted EBITDA.
Other companies may calculate these non-GAAP measures differently
than we do. These non-GAAP measures have limitations as analytical
tools, and you should not consider them in isolation or as a
substitute for our financial results prepared in accordance with
GAAP.
Reconciliation of GAAP Net Income (Loss) to Non-GAAP EBITDA
and Adjusted EBITDA
A reconciliation of GAAP net income (loss) to the non-GAAP
measures of EBITDA and adjusted EBITDA is provided below. EBITDA
represents net income (loss) before interest expense, income tax
expense, net other income and depreciation and amortization.
Adjusted EBITDA represents EBITDA excluding costs incurred
due to changes in the fair value of the warrant liability, debt
extinguishment, stock-based compensation, vendor separation fees,
certain nonrecurring legal fees, Board special committee costs,
executive interim and search costs, severance costs and showroom
opening costs. We believe EBITDA and Adjusted EBITDA provide
additional useful information with respect to the impact of various
adjustments and provide meaningful measures of our operating
performance.
|
|
Three Months
Ended March
31,
|
|
|
|
2024
|
|
|
2023
|
|
|
|
|
|
|
|
|
GAAP net
loss
|
|
$
|
(50,268)
|
|
|
|
(26,052)
|
|
Interest
expense
|
|
|
4,474
|
|
|
|
202
|
|
Income tax (benefit)
expense
|
|
|
59
|
|
|
|
72
|
|
Other (income) expense,
net
|
|
|
(4,394)
|
|
|
|
(73)
|
|
Depreciation and
amortization
|
|
|
6,382
|
|
|
|
6,883
|
|
EBITDA
|
|
|
(43,747)
|
|
|
|
(18,968)
|
|
Adjustments:
|
|
|
|
|
|
|
|
|
Change in fair value -
warrant liability
|
|
|
23,599
|
|
|
|
—
|
|
Loss on extinguishment
of debt
|
|
|
3,394
|
|
|
|
1,217
|
|
Stock-based
compensation expense
|
|
|
492
|
|
|
|
1,192
|
|
Vendor separation
fee
|
|
|
—
|
|
|
|
1,050
|
|
Legal fees
|
|
|
837
|
|
|
|
1,350
|
|
Board special committee
fees
|
|
|
—
|
|
|
|
5,862
|
|
Executive interim and
search costs
|
|
|
1,448
|
|
|
|
789
|
|
Severance
costs
|
|
|
780
|
|
|
|
319
|
|
Showroom opening
costs
|
|
|
1
|
|
|
|
57
|
|
Adjusted
EBITDA
|
|
$
|
(13,196)
|
|
|
$
|
(7,132)
|
|
Reconciliation of GAAP Net Income to non-GAAP Adjusted Net
Income and Adjusted Net Income per Diluted Share
Our presentation of adjusted net income assumes that all net
income is attributable to Purple Innovation, Inc. (i.e. there is no
allocation of net income or loss to noncontrolling interests),
which assumes the full exchange at the beginning of the period of
all outstanding Paired Securities for shares of Class A common
stock of Purple Innovation, Inc., adjusted for certain nonrecurring
items that we do not believe directly reflect our core operations.
Adjusted net income per share, diluted, is calculated by dividing
adjusted net income by the total shares of Class A common stock
outstanding plus any dilutive warrants, options and restricted
stock as calculated in accordance with GAAP and assuming the full
exchange of all outstanding Paired Securities as of the beginning
of each period presented. Adjusted net income and adjusted net
income per diluted share, are supplemental measures of operating
performance that do not represent, and should not be considered,
alternatives to net income and earnings per share, as calculated in
accordance with GAAP. We believe adjusted net income and adjusted
net income per diluted share, supplement GAAP measures and enable
us to more effectively evaluate our performance period-over-period.
A reconciliation of net income (loss), the most directly comparable
GAAP measure, to adjusted net income and the computation of
adjusted net income per diluted share, are set forth below:
|
|
Three Months
Ended
March 31,
|
|
|
|
|
2024
|
|
|
2023
|
|
Net loss
|
|
$
|
(50,268)
|
|
|
$
|
(26,052)
|
|
Income tax (benefit)
expense, as reported
|
|
|
59
|
|
|
|
72
|
|
Change in fair value –
warrant liabilities
|
|
|
23,599
|
|
|
|
—
|
|
Loss on extinguishment
of debt
|
|
|
3,394
|
|
|
|
1,217
|
|
Proceeds from insurance
settlement
|
|
|
(4,300)
|
|
|
|
—
|
|
Board special committee
fees
|
|
|
—
|
|
|
|
5,862
|
|
Adjusted net loss
before income taxes
|
|
|
(27,516)
|
|
|
|
(18,901)
|
|
Adjusted income
taxes(1)
|
|
|
7,127
|
|
|
|
4,895
|
|
Adjusted net
loss
|
|
$
|
(20,389)
|
|
|
$
|
(14,006)
|
|
|
|
|
|
|
|
|
|
|
Adjusted net income per
share, diluted
|
|
$
|
(0.19)
|
|
|
$
|
(0.14)
|
|
|
|
|
|
|
|
|
|
|
Adjusted
weighted-average shares outstanding,
diluted(2)
|
|
|
106,227
|
|
|
|
98,852
|
|
|
|
|
|
|
|
|
(1) Represents the
estimated effective tax rate of 25.9% for the three months ended
March 31, 2024 and 2023, respectively, applied to adjusted net
income before income taxes. The estimated effective tax rates are
what the Company would be subject to and consist of the combined
federal statutory tax rate and the Company's blended state tax
rates, assuming no valuation allowance.
|
|
(2) Assumes dilutive
warrants, options and restricted stock calculated in accordance
with GAAP and the full exchange of all outstanding Paired
Securities for shares of Class A common stock as of the beginning
of the period.
|
A reconciliation of net loss per share, diluted, to adjusted net
loss per share, diluted is set forth below for the three months
ended March 31, 2024 and 2023:
|
|
For the Three Months
Ended
|
|
|
|
March 31,
2024
|
|
|
March 31,
2023
|
|
|
|
Net
Income
|
|
|
Weighted
Average
Shares,
Diluted
|
|
|
Net Loss
per
Share,
Diluted
|
|
|
Net
Income
|
|
|
Weighted
Average
Shares,
Diluted
|
|
|
Net Loss
per Share,
Diluted
|
|
Net loss attributable
to Purple
Innovation Inc.(1)
|
|
$
|
(50,217)
|
|
|
|
106,022
|
|
|
$
|
(0.47)
|
|
|
$
|
(25,933)
|
|
|
|
98,852
|
|
|
$
|
(0.26)
|
|
Assumed exchange of
shares(2)
|
|
|
(51)
|
|
|
|
205
|
|
|
|
|
|
|
|
(119)
|
|
|
|
—
|
|
|
|
|
|
Net loss
|
|
|
(50,268)
|
|
|
|
|
|
|
|
|
|
|
|
(26,052)
|
|
|
|
|
|
|
|
|
|
Adjustments to arrive
at adjusted
income before taxes(3)
|
|
|
22,752
|
|
|
|
|
|
|
|
|
|
|
|
7,151
|
|
|
|
|
|
|
|
|
|
Adjusted loss before
taxes
|
|
|
(27,516)
|
|
|
|
|
|
|
|
|
|
|
|
(18,901)
|
|
|
|
|
|
|
|
|
|
Adjusted income
taxes(4)
|
|
|
7,127
|
|
|
|
|
|
|
|
|
|
|
|
4,895
|
|
|
|
|
|
|
|
|
|
Adjusted net
loss
|
|
$
|
(20,389)
|
|
|
|
106,227
|
|
|
$
|
(0.19)
|
|
|
$
|
(14,006)
|
|
|
|
98,852
|
|
|
$
|
(0.14)
|
|
|
(1) Represents
net income attributable to Purple Innovation, Inc. and the
associated weighted average dilutive shares, of Class A common
stock outstanding.
|
|
(2) Assumes the
addition of net income attributable to noncontrolling interests
corresponding with the assumed exchange of the Paired Securities
for shares of Class A common stock. For the three months
ended March 31, 2023, the assumed full exchange of all outstanding
Paired Securities for shares of Class A common stock as of the
beginning of the period was included in the calculation of the
Weighted Average Shares, Diluted on the previous line as the effect
was dilutive.
|
|
(3) Represents the
total impact of all adjustments identified in the adjusted net
income table above to arrive at adjusted income before income
taxes. Also assumes the dilutive warrants, options and restricted
stock as calculated in accordance with GAAP.
|
|
(4) Represents the
estimated effective tax rate of 25.9% for the three months ended
March 31, 2024 and 2023, applied to adjusted net income before
income taxes. The estimated effective tax rates are what the
Company would be subject to and consist of the combined federal
statutory tax rate and the Company's blended state tax rates,
assuming no valuation allowance.
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/purple-innovation-reports-first-quarter-2024-results-302138622.html
SOURCE Purple Innovation, Inc.